Literature DB >> 8109884

Epithelial malignancies of the lacrimal gland: survival rates after extensive and conservative therapy.

E Polito1, A Leccisotti.   

Abstract

We reviewed 96 cases of lacrimal gland tumors; 20 patients had epithelial malignancies (11 adenoid cystic carcinomas, 7 carcinomas in pleiomorphic adenomas, 1 mucoepidermoid tumor, 1 adenocarcinoma, and 1 carcinoma in an epidermoid cyst). Classic computed tomographic scan changes associated with lacrimal gland malignancies were found in only 55% of cases. The median survival was 6.75 years in the seven patients treated with extensive surgery (orbital exenteration, possibly associated with osseous resections) and nine years in the 12 cases treated with eye-saving procedures (tumor excision, possibly followed by radiotherapy). Our data demonstrated that extensive surgery for lacrimal gland malignancies does not improve survival. Therefore, a therapeutic protocol is suggested, in which all suspected epithelial tumors (discriminated from inflammatory and lymphoid lesions by computed tomographic scan findings) undergo dacryoadenectomy, without a previous biopsy. Subsequently, in the case of carcinomas, the choice between extensive and eye-saving procedures is based on the extent and aggressiveness of the tumor and clinical findings.

Entities:  

Mesh:

Year:  1993        PMID: 8109884

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  9 in total

1.  Orbital exenteration: surgical and reconstructive strategies.

Authors:  C Mohr; J Esser
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-05       Impact factor: 3.117

2.  Prognosis of orbital lymphoid hyperplasia.

Authors:  E Polito; A Leccisotti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

3.  Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.

Authors:  David T Tse
Journal:  Trans Am Ophthalmol Soc       Date:  2005

4.  Mortality following exenteration for malignant tumours of the orbit.

Authors:  I Rahman; A Maino; A E Cook; B Leatherbarrow
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

5.  Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.

Authors:  David T Tse; Pasquale W Benedetto; Brian C Tse; William J Feuer
Journal:  Am J Ophthalmol       Date:  2022-04-02       Impact factor: 5.488

6.  Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.

Authors:  David T Tse; Andrea L Kossler; William J Feuer; Pasquale W Benedetto
Journal:  Ophthalmology       Date:  2013-04-09       Impact factor: 12.079

7.  Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety.

Authors:  Sati Akbaba; Kristin Lang; Thomas Held; Klaus Herfarth; Juliane Rieber; Peter Plinkert; Gerd U Auffarth; Stefan Rieken; Juergen Debus; Sebastian Adeberg
Journal:  Cancer Manag Res       Date:  2019-02-01       Impact factor: 3.989

8.  Pleomorphic adenocarcinoma of the lacrimal gland with multiple intracranial and spinal metastases.

Authors:  Jung Yong Ahn; Jong Hee Chang; Se Hoon Kim; Kyu Sung Lee
Journal:  World J Surg Oncol       Date:  2007-03-07       Impact factor: 2.754

9.  Expression of Autophagy and Reactive Oxygen Species-Related Proteins in Lacrimal Gland Adenoid Cystic Carcinoma.

Authors:  Ja Seung Koo; Ji Won Kim; Jin Sook Yoon
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.